# Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19

> **NCT04486313** · PHASE3 · COMPLETED · sponsor: **Romark Laboratories L.C.** · enrollment: 935 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Nitazoxanide
- **DRUG:** Placebo
- **DIETARY_SUPPLEMENT:** Vitamin Super B-Complex

## Key facts

- **NCT ID:** NCT04486313
- **Lead sponsor:** Romark Laboratories L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-13
- **Primary completion:** 2021-02-08
- **Final completion:** 2021-02-08
- **Target enrollment:** 935 (ACTUAL)
- **Last updated:** 2024-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04486313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04486313, "Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Mild or Moderate COVID-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04486313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*